Skip to content
Recall Observatory FDA recall evidence

Drug product

Pramipexole dihydrochloride extended release tablets, 0.75 mg, packaged in 30-count bottles, Rx only, Manufactured by: Par Pharmaceutical, Chestnut Ridge, NY 10977, NDC 10370-252-11

D-1185-2018

September 06, 2018

Class III

Product summary

Firm
Par Pharmaceutical, Inc.
Event
Event 80969
Status
Terminated
Classification
Class III
Quantity
16,207 (bottles of 30 tablets)
Official record key
drug-enforcement:D-1185-2018

Official wording

Reason: Failed impurities/degradation specifications: Finished product contain a known product impurity about current specification levels.

Code information: Lot #: 29906202, Exp 12/18; 29993102, Exp 2/19; 30366102, 30373103, Exp 4/19; 31940601, Exp 3/20.

Distribution pattern: United States nationwide

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Failed impurities/degradation specifications